He suffers debilitating side effects from a common medication. A simple test could have spared him. Why won’t Ontario and other provinces make the tests more widely available?
The U.K. aims to make pharmacogenomic tests more accessible, saying systematic testing “has the potential to transform patient’s lives.”... Read more.